Clinical Trials Directory

Trials / Completed

CompletedNCT02042742

Punicalagin and Hydroxytyrosol Mixture on Different Inflammatory Markers

Effects of Punicalagin and Hydroxytyrosol Mixture on Different Inflammatory Markers Related With Cardiovascular Disease: a Crossover Study in Healthy Middle-aged Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

A crossover trial was carried out in healthy volunteers aged 45-70 years and BMI \<30 kg/m2. Subjects consumed a Antioxidant Supplement (AS) containing 65 mg of punicalagin mixed with 3.3 mg of hydroxytyrosol 3 times daily or a Control Supplement (CS) with maltodextrin for an 8 wk each phase with 4-wk rest period. Supplementation order was randomly assigned and the consumption of derivative products of punicalagin and/or hydroxytyrosol restricted. The endothelial function parameters (brachial artery flow-mediated dilation (FMD), biochemical markers), inflammatory markers and nutritional status were evaluated before and after each phase. Previously a pilot study was completed with no placebo (n=30) to determinate the effective dose of Functional Supplement.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTpunicalagin and hydroxytyrosol mixtureAntioxidant Supplement (punicalagin and hydroxytyrosol mixture) During one period of crossover study (I or II) volunteers consume daily of functional supplement during 8 weeks. Additionally, volunteers must follow guidelines for healthy diet and physical activity.
DIETARY_SUPPLEMENTControl supplement (maltodextrin)During one period of crossover study (I or II) volunteers consume daily of functional supplement during 8 weeks. Additionally, volunteers must follow guidelines for healthy diet and physical activity.

Timeline

Start date
2013-04-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2014-01-23
Last updated
2014-01-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02042742. Inclusion in this directory is not an endorsement.